Related references
Note: Only part of the references are listed.Therapy resistance mechanisms in hematological malignancies
Wolf-Karsten Hofmann et al.
INTERNATIONAL JOURNAL OF CANCER (2023)
Cavβ1 regulates T cell expansion and apoptosis independently of voltage-gated Ca2+ channel function
Serap Erdogmus et al.
NATURE COMMUNICATIONS (2022)
mTOR inhibition downregulates glucose-6-phosphate dehydrogenase and induces ROS-dependent death in T-cell acute lymphoblastic leukemia cells
Micol Silic-Benussi et al.
REDOX BIOLOGY (2022)
Targeting mitochondrial ion channels for cancer therapy
Ildiko Szabo et al.
REDOX BIOLOGY (2021)
Stress Relief Techniques: p38 MAPK Determines the Balance of Cell Cycle and Apoptosis Pathways
Robert H. Whitaker et al.
BIOMOLECULES (2021)
Exploiting the metabolic energy demands of drug efflux pumps provides a strategy to overcome multidrug resistance in cancer
Xuexin Gao et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2021)
Therapeutic Targeting of mTOR in T-Cell Acute Lymphoblastic Leukemia: An Update
Camilla Evangelisti et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Selective killing of human T-ALL cells: an integrated approach targeting redox homeostasis and the OMA1/OPA1 axis
Micol Silic-Benussi et al.
CELL DEATH & DISEASE (2018)
Pediatric T-Cell Acute Lymphoblastic Leukemia
Kristina Karrman et al.
GENES CHROMOSOMES & CANCER (2017)
Combenefit: an interactive platform for the analysis and visualization of drug combinations
Giovanni Y. Di Veroli et al.
BIOINFORMATICS (2016)
The Role of Multidrug Resistance Efflux Pumps in Cancer: Revisiting a JNCI Publication Exploring Expression of the MDR1 (P-glycoprotein) Gene
Michael M. Gottesman et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
The Role of Multidrug Resistance Efflux Pumps in Cancer: Revisiting a JNCI Publication Exploring Expression of the MDR1 (P-glycoprotein) Gene
Michael M. Gottesman et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Therapeutic antibody targeting of Notch1 in T-acute lymphoblastic leukemia xenografts
V. Agnusdei et al.
LEUKEMIA (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
Collateral sensitivity as a strategy against cancer multidrug resistance
Kristen M. Pluchino et al.
DRUG RESISTANCE UPDATES (2012)
Inhibitors of mitochondrial Kv1.3 channels induce Bax/Bak-independent death of cancer cells
Luigi Leanza et al.
EMBO MOLECULAR MEDICINE (2012)
Glucocorticoid resistance in paediatric acute lymphoblastic leukaemia
Vivek A. Bhadri et al.
JOURNAL OF PAEDIATRICS AND CHILD HEALTH (2012)
Intracellular reactive oxygen species are essential for PI3K/Akt/mTOR-dependent IL-7-mediated viability of T-cell acute lymphoblastic leukemia cells
A. Silva et al.
LEUKEMIA (2011)
Redox regulation of T-cell turnover by the p13 protein of human T-cell leukemia virus type 1: distinct effects in primary versus transformed cells
Micol Silic-Benussi et al.
BLOOD (2010)
Modulation of mitochondrial K+ permeability and reactive oxygen species production by the p13 protein of human T-cell leukemia virus type 1
Micol Silic-Benussi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2009)
The functional network of ion channels in T lymphocytes
Michael D. Cahalan et al.
IMMUNOLOGICAL REVIEWS (2009)
PTEN posttranslational inactivation and hyperactivation of the PI3K/Akt pathway sustain primary T cell leukemia viability
Ana Silva et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Calcium and apoptosis: ER-mitochondria Ca2+ transfer in the control of apoptosis
P. Pinton et al.
ONCOGENE (2008)
Side population analysis using a violet-excited cell-permeable DNA binding dye
William G. Telford et al.
STEM CELLS (2007)
Expression of multidrug resistance-associated proteins predicts prognosis in childhood and adult acute lymphoblastic leukemia
SLA Plasschaert et al.
CLINICAL CANCER RESEARCH (2005)
K+ channels as targets for specific immunomodulation
KG Chandy et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2004)
Verapamil and its derivative trigger apoptosis through glutathione extrusion by multidrug resistance protein MRP1
D Trompier et al.
CANCER RESEARCH (2004)
The multidrug resistance-associated protein 3 (MRP3) is associated with a poor outcome in childhood ALL and may account for the worse prognosis in male patients and T-cell immunophenotype
D Steinbach et al.
BLOOD (2003)
Gene Expression Omnibus: NCBI gene expression and hybridization array data repository
R Edgar et al.
NUCLEIC ACIDS RESEARCH (2002)
Verapamil-stimulated glutathione transport by the multidrug resistance-associated protein (MRP1) in leukaemia cells
KV Cullen et al.
BIOCHEMICAL PHARMACOLOGY (2001)
Share Paper
